ArticleCancers2022

White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer Therapy.

Edgar Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.